Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

Columbia University Medical Center, New York

Duke Neurological Disorders Clinic at Morreene Road, Durham

Carolinas Medical Center, Neurosciences Instutite-Neurology, Charlotte

Emory University, Department of Neurology, Atlanta

Mayo Clinic Florida, Jacksonville

University of Miami Miller School of Medicine, Miami

The Ohio State University Wexner Medical Center, Columbus

Cleveland Clinic Foundation-Cleveland Clinic Hospital, Cleveland

Clinical & Translational Science Institute, University of Minnesota, Minneapolis

Washington University School of Medicine, St Louis

University of Kansas Medical Center, Kansas City

Houston Methodist Neurological Institute, Houston

University of Texas Health Sciences Center San Antonio, San Antonio

St. Joseph's Hospital and Medical Center - Barrow Neurology Clinics, Phoenix

Mayo Clinic Arizona, Scottsdale

Cedars-Sinai Medical Center, Los Angeles

University of California, Irvine, Department of Neurology, Orange

Forbes Norris MDA/ALS Research Center, CPMC, San Francisco

Providence Brain & Spine Institute, ALS Center, Portland

University of Kentucky, Albert B. Chandler Medical Center, Lexington

Massachusetts General Hospital, Boston

Montreal Neurological Institute, Montreal